A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

Phase 1 study, condition: Diabetes Mellitus, Insulin Sensitivity. The primary objective of Study GZQG is to compare the effect of retatrutide and placebo on total clamp disposition index (cDI) after 28 weeks of treatment. Enrolment: 95 participants. Status: active, not recruiting. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.